Using blood cell ratios and procalcitonin to predict outcomes for adults with sepsis in the ICU
Official title: Comparison Between Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.
Run by Ain Shams University · NCT07200817 · Data updated 2026-11-12
This project will test whether routine blood measures—neutrophil-to-lymphocyte-and-platelet ratio, procalcitonin, and total white blood cell count—can help predict outcomes for adults with sepsis in the intensive care unit.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 290 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | September 20, 2024 |
| Main results expected | March 19, 2026 |
| Study ends | March 19, 2026 |
| Registry record updated | October 1, 2025 |
| Trial ID | NCT07200817 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18–70 who are admitted to the ICU with sepsis (per current sepsis definitions) and who do not have the listed exclusion conditions.
✕Probably not a fit
Patients who are pregnant, have active malignancy, are on immunosuppressive therapy, have hematologic disorders, major trauma or burns, Child-Pugh C cirrhosis, or are on hemodialysis are excluded and would not receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational ICU study that will collect routine laboratory values (neutrophil-to-lymphocyte-and-platelet ratio, procalcitonin, and total leukocyte count) from adult patients diagnosed with sepsis. Researchers will compare these biomarkers to patients' clinical outcomes such as mortality, organ failure, and length of ICU stay to see which markers best correlate with prognosis. The study excludes patients with pregnancy, malignancy, immunosuppression, hematologic disorders, major trauma or burns, advanced liver cirrhosis, or those on hemodialysis. No investigational treatments are given; data are drawn from standard care blood tests and clinical records.
Why it matters
Potential benefit: If successful, these low-cost, routinely available blood markers could help clinicians identify higher-risk sepsis patients earlier and better target monitoring and treatment.
How similar studies have gone: Previous studies have shown that procalcitonin and neutrophil/lymphocyte-based ratios often correlate with sepsis severity and mortality, but results have been variable and not yet definitive for routine prognostic use.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 18 to 70 years old. * Both sexes. * Septic patients (under the third international consensus definitions of sepsis and septic shock). Exclusion Criteria: * Pregnancy * Malignancy * On immunosuppressive therapy * Hematological Disorders * Major Trauma * Major Burns * Child-Pugh Class C Liver Cirrhosis * On Hemodialysis
Where it's running
-
Ain Shams University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Michael G Farag, Master
- Email: MICHAELFARAG@med.asu.edu.eg
- Phone: 00201278142328
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genomic changes of Klebsiella pneumoniae and Enterobacter cloacae in ICU patients over time
This study tests how the gut bacteria Klebsiella pneumoniae and Enterobacter cloacae evolve over time in adults in ICUs.
-
Two eye care methods to prevent eye problems in ventilated ICU patients
This tests whether using an eye care kit, a written eye-care protocol, or both will reduce eye complications compared with standard care in adults on mechanical ventilation in the ICU.
-
Autologous Cold-Stored Platelets for Complex Cardiac Surgery
This study tests whether using a patient’s own cold-stored platelets, donated 7–10 days before surgery, improves outcomes for adults undergoing complex cardiac procedures compared with standard allogeneic platelets.
-
Virtual reality to improve comfort for adults in the surgical ICU
This trial will try immersive virtual reality (HypnoVR) sessions to reduce discomfort for adults who stay at least 48 hours in the surgical intensive care unit after major cardiothoracic or abdominal surgery.
-
Using a device to recover platelets during cardiac surgery
This study tests if a special device that collects and returns your own blood during heart surgery can help keep your platelet levels up and reduce the need for blood transfusions.
-
Calibration of esophageal balloon catheter for patients on mechanical ventilation
This study is testing how to better calibrate a special balloon used in the esophagus to measure pressure in patients on mechanical ventilation, to see if it helps improve their care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.